Exercise or conversion
Manuela Valente
Chief People Officer
Ordinary Shares
- Value context
- $32K
- Reported price
- $3.20 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
SOPHiA GENETICS SA
Last 30 daysNo qualifying insider buying. Sales: $912.77K by 10 insiders.
Showing the first 6 of 20 trades on this page.
Chief People Officer
Ordinary Shares
Chief People Officer
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Scientific Officer
Ordinary Shares
Chief Scientific Officer
Ordinary Shares
Chief Scientific Officer
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Scientific Officer
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Executive Chairman
Ordinary Shares
Executive Chairman
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Executive Chairman
Ordinary Shares
Executive Chairman
Ordinary Shares
Executive Chairman
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Executive Chairman
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Executive Officer
Ordinary Shares
Chief Executive Officer
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Ordinary Shares
Director
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
Director
Ordinary Shares
Director
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
Director
Ordinary Shares
Director
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Chief People Officer | Ordinary SharesOption exercise or conversion10b5-1 | 10,000$3.20 / share | $32K | Aug 19Filed Aug 21 · 2d later | SEC filing |
| Chief People Officer | Share Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units10,000$3.20 exercise / conversion price | Not a separate purchase | Aug 19Filed Aug 21 · 2d later | SEC filing |
| Chief Scientific Officer | Ordinary SharesOption exercise or conversion10b5-1 | 3,000$3.28 / share | $9.84K | Aug 5Filed Aug 7 · 2d later | SEC filing |
| Chief Scientific Officer | Ordinary SharesOption exercise or conversion10b5-1 | 7,000$3.28 / share | $22.96K | Aug 7Filed Aug 7 · 0d later | SEC filing |
| Chief Scientific Officer | Share Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units3,000$3.28 exercise / conversion price | Not a separate purchase | Aug 5Filed Aug 7 · 2d later | SEC filing |
| Chief Scientific Officer | Share Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units7,000$3.28 exercise / conversion price | Not a separate purchase | Aug 7Filed Aug 7 · 0d later | SEC filing |
| Executive Chairman | Ordinary SharesOption exercise or conversion10b5-1 | 4,581$3.16 / share | $14.48K | Jul 20Filed Jul 22 · 2d later | SEC filing |
| Executive Chairman | Share Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units4,581$3.16 exercise / conversion price | Not a separate purchase | Jul 20Filed Jul 22 · 2d later | SEC filing |
| Executive Chairman | Ordinary SharesOption exercise or conversion10b5-1 | 18,060$3.16 / share | $57.07K | Jun 29Filed Jul 1 · 2d later | SEC filing |
| Executive Chairman | Ordinary SharesOption exercise or conversion10b5-1 | 45,419$3.16 / share | $143.52K | Jun 30Filed Jul 1 · 1d later | SEC filing |
| Executive Chairman | Share Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units18,060$3.16 exercise / conversion price | Not a separate purchase | Jun 29Filed Jul 1 · 2d later | SEC filing |
| Executive Chairman | Share Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units45,419$3.16 exercise / conversion price | Not a separate purchase | Jun 30Filed Jul 1 · 1d later | SEC filing |
| Chief Executive Officer | Ordinary SharesOption exercise or conversion10b5-1 | 31,940$3.16 / share | $100.93K | Jun 26Filed Jun 29 · 3d later | SEC filing |
| Chief Executive Officer | Share Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units31,940$3.16 exercise / conversion price | Not a separate purchase | Jun 26Filed Jun 29 · 3d later | SEC filing |
| Director | Ordinary SharesGrant or award | 19,724$5.46 / share | $107.69K | Jun 18Filed Jun 22 · 4d later | SEC filing |
| Director | Share Option (Right to Buy)Grant or award | Derivative units28,818$5.46 / derivative unit | $157.35K | Jun 18Filed Jun 22 · 4d later | SEC filing |
| Director | Ordinary SharesGrant or award | 19,724$5.46 / share | $107.69K | Jun 18Filed Jun 22 · 4d later | SEC filing |
| Director | Share Option (Right to Buy)Grant or award | Derivative units28,818$5.46 / derivative unit | $157.35K | Jun 18Filed Jun 22 · 4d later | SEC filing |
| Director | Ordinary SharesGrant or award | 19,724$5.46 / share | $107.69K | Jun 18Filed Jun 22 · 4d later | SEC filing |
| Director | Share Option (Right to Buy)Grant or award | Derivative units28,818$5.46 / derivative unit | $157.35K | Jun 18Filed Jun 22 · 4d later | SEC filing |
Showing the latest 20 of 60 trades. Show all 60 trades
This reflects the filings imported so far, not a complete trading history.
$24,750 of common-equity purchase value after transaction-age decay across 180 days.
1 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.